enVVeno Medical (NVNO) 10-Q2020 Q1 Quarterly report

Filed: 8 Jun 20, 5:01pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: absence, accessing, accomplished, accurate, accurately, active, actively, activity, adequacy, Aid, Amelia, American, annum, anterior, anticoagulation, aorta, ascending, aspirated, assimilated, assumed, ASU, authorized, barrier, bear, biocompatibility, bridge, burden, CA, Carlo, circumvention, civil, Clara, Codification, combination, combined, commencing, commonly, comply, concept, concurrent, confidence, consolidated, corroborated, Coumadin, criminal, custody, deadline, decline, deducting, deficiency, delayed, department, descending, detailed, difficult, directly, disrupted, doppler, drafted, economy, enacted, endothelial, endothelialization, Endothelium, entity, eroded, Erosion, essential, exit, experiencing, explore, exposure, face, fairly, FASB, fluctuate, fluid, Forum, forward, framework, goodwill, governance, government, guidance, harm, health, healthcare, healthy, hierarchy, hold, holding, human, identical, impact, impacted, impacting, implement, incorporating, indirectly, induration, industry, infection, inflammation, instrument, intolerance, Island, judgement, lab, larger, layer, level, liability, Likewise, loan, local, lose, mandated, manner, maximize, memory, met, mild, minimize, misstatement, monitoring, Monte, natural, naturally, nature, necropsy, nonemployee, Notwithstanding, objectively, observable, occluded, orderly, outbreak, ownership, pandemic, passage, patent, pathology, pending, permitted, pigmentation, pocket, preformed, presence, procurement, produce, promote, proof, purpose, quarantine, quotable, quoted, ranged, reaching, reclassification, reclassified, Reference, regularly, reliability, reliable, Relief, remotely, reverse, review, revision, Santa, scope, scrutiny, selected, served, shareholder, sheep, sheriff, showed, simplify, simulation, skin, smooth, sought, split, submission, sufficient, suit, summary, technical, therapy, top, trading, understanding, unknown, unobservable

Removed: Alexander, allocated, allocation, Alternatively, amendment, amortization, anniversary, arrangement, beneficial, bid, Black, CEO, cliff, Columbia, consideration, consummation, contractual, conversion, converted, cumulative, customer, death, declared, deemed, depending, determination, dividend, embedded, employment, equally, exceeding, exemption, extended, extinguishment, feature, focused, generate, identification, ii, iii, introducing, iv, join, labor, licensed, mammary, member, Network, occurring, offset, partially, participated, passed, pertaining, Peter, point, portion, preferred, President, principally, provision, recognition, recognize, registration, resulted, Sarner, satisfied, satisfy, secure, supporting, timing, unconditional, unsatisfied, Vice

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

NVNO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hancock Jaffe Laboratories, Inc. (the “Company’s Quarterly Report”) on Form 10-Q for the period ended March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Robert Berman, as Chief Executive Officer and principal executive officer and Craig Glynn, as Chief Financial Officer and principal financial officer of the Company hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of the undersigned’s knowledge and belief, that:

	1.	The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
	2.	Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

/s/ Robert Berman
Robert Berman
Chief Executive Officer and Principal Executive Officer

Dated: June 8, 2020

/s/ Craig Glynn
Craig Glynn
Chief Financial Officer and Principal Financial Officer

Dated: June 8, 2020

This certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.